Long term safety and efficacy of H1N1 vaccine in a single-center cohort of IBD patients treated with immunomodulators and/or anti-TNFα biologics.
Nikolaos
N
Kyriakos
Konstantinos
K
Papamichael
Emmanuel
E
Archavlis
George
G
Agalos
Gerassimos J
GJ
Mantzaris
D015331:Cohort Studies; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003424:Crohn Disease / Q000188:drug therapy; D005221:Fatigue / Q000209:etiology; D005334:Fever / Q000209:etiology; D006261:Headache / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000009:adverse effects*; D007251:Influenza, Human / Q000517:prevention & control*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D007166:Immunosuppressive Agents; D007252:Influenza Vaccines; D014409:Tumor Necrosis Factor-alpha